Chemoinformaics analysis of Ethyl 3-mercaptopropionate
| Molecular Weight | 134.2 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.12 | nRig | 1 |
| Exact Molecular Weight | 134.04 | nRing | 0 |
| Solubility: LogS | -1.511 | nHRing | 0 |
| Solubility: LogP | 1.248 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 19.5219 |
| nHD | 1 | BPOL | 15.0961 |
| QED | 0.458 |
| Synth | 2.255 |
| Natural Product Likeliness | -0.344 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -4.358 |
| MDCK | 0.0000302 |
| BBB | 0.311 |
| PPB | 0.822138 |
| VDSS | 0.623 |
| FU | 0.366307 |
| CYP1A2-inh | 0.662 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.139 |
| CYP2c19-sub | 0.569 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.361 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.332 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.266 |
| CL | 12.042 |
| T12 | 0.901 |
| hERG | 0.007 |
| Ames | 0.889 |
| ROA | 0.31 |
| SkinSen | 0.594 |
| Carcinogencity | 0.76 |
| EI | 0.982 |
| Respiratory | 0.166 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.964777 |